PMA device
TriClip G4 System
Abbott Medical · Tricuspid Valve Repair Device, Percutaneously Delivered (NPS, Class III) · First FDA decision Apr 1, 2024, newest Nov 13, 2024Tricuspid regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
Breakthrough-designated
Device trials
0
Naming "TriClip G4"
MAUDE reports
1,436
Brand "TriClip G4", since 2015
PubMed studies
2
Mentioning "TriClip G4"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TriClip G4 System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- TriClip G4 SystemPMA supplement
P230007-S007 · Decided Nov 13, 2024 · 29 days after receipt · Normal 180 Day Track No User Fee
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
- TriClip G4 SystemPMA supplement
P230007-S004 · Decided May 31, 2024 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
- TriClip G4 SystemPMA supplement
P230007-S003 · Decided May 31, 2024 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcatheter Edge-to-Edge Repair for Tricuspid Valve Regurgitation (T-TEER)National analysisReview closedCAG-00468NUpdated Sep 23, 2026
- Transcatheter Edge-to-Edge Repair for Tricuspid Valve Regurgitation (T-TEER)National determinationOn the books20.38Updated Jun 2, 2026
- Transcatheter Tricuspid Valve Replacement (TTVR)National analysisReview closedCAG-00467NUpdated Sep 24, 2026
- Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve RegurgitationNational analysisReview closedCAG-00438RUpdated Sep 23, 2026
- Transcatheter Mitral Valve Repair (TMVR)National analysisReview closedCAG-00438RUpdated Sep 23, 2026
- Transcatheter Mitral Valve Repair (TMVR)National analysisReview closedCAG-00438NUpdated Sep 23, 2026
- Transcatheter Tricuspid Valve Replacement (TTVR)National determinationOn the books20.37Updated Jun 2, 2026
- Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve RegurgitationNational determinationOn the books20.33Updated Aug 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "TriClip G4", any status and sponsor, newest update first.
No registered device study names "TriClip G4".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TriClip G4", and for the whole product code for context.
This brand
1,436 reports: 495 malfunction, 930 injury, 11 death
Whole product code NPS
2,254 reports: 792 malfunction, 1,379 injury, 81 death
Newest reports for this brand
- TriClip G4 SystemInjury
2135147-2026-07192 · Received Oct 26, 2026 · Event dated Sep 28, 2026
Device type: Tricuspid Valve Repair Device, Percutaneously Delivered (NPS)
Device problem as coded: Incomplete Coaptation
Patient problem as coded: Tricuspid Valve Insufficiency/ Regurgitation; Unspecified Tissue Injury
- TriClip G4 SystemInjury
2135147-2026-07203 · Received Oct 26, 2026 · Event dated Oct 6, 2026
Device type: Tricuspid Valve Repair Device, Percutaneously Delivered (NPS)
Device problem as coded: Incomplete Coaptation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- TriClip G4 SystemInjury
2135147-2026-07145 · Received Oct 23, 2026 · Event dated Sep 29, 2026
Device type: Tricuspid Valve Repair Device, Percutaneously Delivered (NPS)
Device problem as coded: Incomplete Coaptation
Patient problem as coded: Tricuspid Valve Insufficiency/ Regurgitation; Unspecified Tissue Injury
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TriClip G4"[tiab]. The summary above synthesizes these.
- TriClip G4: A game-changer for tricuspid valve regurgitation treatment.
Mahboob E, Samad MA, Carver C, et al. · Curr Probl Cardiol · 2024Review
- Complimentary Role of ICE and TEE During Transcatheter Edge-to-Edge Tricuspid Valve Repair With TriClip G4.
Wong I, Chui ASF, Wong CY, et al. · JACC Cardiovasc Interv · 2022
Other devices of this type
Also filed under product code NPS.
- PASCAL Precision Transcatheter Valve Repair SystemEdwards Lifesciences, LLC · PMA 2026
- TriClip G5 Delivery SystemAbbott Medical · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.